| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | NADH oxidase H202-forming activity | 5.02e-05 | 2 | 142 | 2 | GO:0106293 | |
| GeneOntologyCellularComponent | multi-pass translocon complex | 2.45e-05 | 9 | 141 | 3 | GO:0160064 | |
| GeneOntologyCellularComponent | inner dynein arm | 3.48e-05 | 10 | 141 | 3 | GO:0036156 | |
| GeneOntologyCellularComponent | ER membrane insertion complex | 1.04e-04 | 14 | 141 | 3 | GO:0072379 | |
| Domain | DUF2012 | 1.57e-06 | 4 | 138 | 3 | PF09430 | |
| Domain | DUF2012 | 1.57e-06 | 4 | 138 | 3 | IPR019008 | |
| Domain | CarboxyPept-like_regulatory | 6.30e-06 | 17 | 138 | 4 | IPR008969 | |
| Domain | Carb-bd-like_fold | 2.15e-05 | 8 | 138 | 3 | IPR013784 | |
| Domain | DUOX1 | 5.42e-05 | 2 | 138 | 2 | IPR029595 | |
| Domain | CarboxyPept_regulatory_dom | 1.07e-04 | 13 | 138 | 3 | IPR014766 | |
| Domain | - | 1.07e-04 | 13 | 138 | 3 | 2.60.40.1120 | |
| Domain | Dynein_heavy_chain_D4_dom | 1.35e-04 | 14 | 138 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 1.35e-04 | 14 | 138 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 1.35e-04 | 14 | 138 | 3 | IPR013602 | |
| Domain | DHC_N2 | 1.35e-04 | 14 | 138 | 3 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 1.35e-04 | 14 | 138 | 3 | IPR011704 | |
| Domain | MT | 1.35e-04 | 14 | 138 | 3 | PF12777 | |
| Domain | AAA_8 | 1.35e-04 | 14 | 138 | 3 | PF12780 | |
| Domain | AAA_5 | 1.35e-04 | 14 | 138 | 3 | PF07728 | |
| Domain | DHC_fam | 1.68e-04 | 15 | 138 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 1.68e-04 | 15 | 138 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 1.68e-04 | 15 | 138 | 3 | IPR004273 | |
| Domain | GATASE_TYPE_2 | 5.34e-04 | 5 | 138 | 2 | PS51278 | |
| Domain | GATase_2_dom | 5.34e-04 | 5 | 138 | 2 | IPR017932 | |
| Domain | NAD_binding_6 | 1.11e-03 | 7 | 138 | 2 | PF08030 | |
| Domain | FAD_binding_8 | 1.11e-03 | 7 | 138 | 2 | PF08022 | |
| Domain | FAD-bd_8 | 1.11e-03 | 7 | 138 | 2 | IPR013112 | |
| Domain | Fe_red_NAD-bd_6 | 1.11e-03 | 7 | 138 | 2 | IPR013121 | |
| Domain | Helicase_C | 1.19e-03 | 107 | 138 | 5 | PF00271 | |
| Domain | HELICc | 1.19e-03 | 107 | 138 | 5 | SM00490 | |
| Domain | Helicase_C | 1.24e-03 | 108 | 138 | 5 | IPR001650 | |
| Domain | HELICASE_CTER | 1.29e-03 | 109 | 138 | 5 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 1.29e-03 | 109 | 138 | 5 | PS51192 | |
| Domain | DEXDc | 1.29e-03 | 109 | 138 | 5 | SM00487 | |
| Domain | Helicase_ATP-bd | 1.35e-03 | 110 | 138 | 5 | IPR014001 | |
| Domain | Chond_GalNAc | 1.47e-03 | 8 | 138 | 2 | IPR008428 | |
| Domain | CHGN | 1.47e-03 | 8 | 138 | 2 | PF05679 | |
| Pubmed | ERCC6 ZNF484 LEMD3 ETS2 ERBIN NOMO1 ARHGAP5 LIMK2 AP1G1 UBR5 ANAPC2 STX16 NOMO3 TBCD DNM2 | 2.47e-08 | 591 | 143 | 15 | 15231748 | |
| Pubmed | 6.81e-08 | 3 | 143 | 3 | 36011023 | ||
| Pubmed | Silencing of nodal modulator 1 inhibits the differentiation of P19 cells into cardiomyocytes. | 6.81e-08 | 3 | 143 | 3 | 25576386 | |
| Pubmed | DOCK3 POLG ETS2 TFIP11 RAD54L2 CMYA5 GTF3C4 SH2B1 MICU1 CSDE1 ARHGAP5 TUBB4A APPL2 SLF2 NOMO2 CTNNA1 GFPT2 RAPGEF2 PCM1 AFF4 DNM2 | 7.38e-08 | 1285 | 143 | 21 | 35914814 | |
| Pubmed | Hepatic lipase maturation: a partial proteome of interacting factors. | 1.71e-07 | 31 | 143 | 5 | 19136429 | |
| Pubmed | Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology. | 2.71e-07 | 4 | 143 | 3 | 31833031 | |
| Pubmed | 2.71e-07 | 4 | 143 | 3 | 11175280 | ||
| Pubmed | 2.71e-07 | 4 | 143 | 3 | 9267806 | ||
| Pubmed | SEMA3C EPB41L4B PEX3 GON4L TFIP11 RAD54L2 CSDE1 PRR12 AP1G1 ANAPC2 ANKIB1 ZNF638 GIGYF2 DNM2 | 5.37e-07 | 650 | 143 | 14 | 38777146 | |
| Pubmed | SEMA3C ERCC6 TBC1D30 LEMD3 POLR2A ETV6 GON4L TFIP11 ERBIN NOMO1 MICU1 CSDE1 PRR12 MYOF APPL2 AP1G1 MIOS STX16 ATP5PD AFF4 | 3.51e-06 | 1497 | 143 | 20 | 31527615 | |
| Pubmed | Nicalin and its binding partner Nomo are novel Nodal signaling antagonists. | 3.75e-06 | 8 | 143 | 3 | 15257293 | |
| Pubmed | 3.75e-06 | 8 | 143 | 3 | 10444069 | ||
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | HSP90B2P POLR2A DDX5 PRR12 ARHGAP5 TENM4 MIOS PKP1 SMARCD2 RAPGEF2 PCM1 | 4.71e-06 | 475 | 143 | 11 | 31040226 |
| Pubmed | Substrate-driven assembly of a translocon for multipass membrane proteins. | 5.61e-06 | 9 | 143 | 3 | 36261522 | |
| Pubmed | HSP90B2P EPB41L4B ERBIN DDX5 CSDE1 ARHGAP5 MLXIPL TUBB4A TENM4 APPL2 AP1G1 MIOS CTNNA1 CPNE4 RAPGEF2 DNAH6 ATP5PD PCM1 DNM2 | 6.88e-06 | 1431 | 143 | 19 | 37142655 | |
| Pubmed | GTF3C4 DARS2 NOMO1 METTL13 DCAF10 NOMO2 DHFR ADPGK NOMO3 TBCD DNM2 VAT1 | 8.41e-06 | 606 | 143 | 12 | 36538041 | |
| Pubmed | An ER translocon for multi-pass membrane protein biogenesis. | 1.10e-05 | 11 | 143 | 3 | 32820719 | |
| Pubmed | Digenic DUOX1 and DUOX2 Mutations in Cases With Congenital Hypothyroidism. | 1.68e-05 | 2 | 143 | 2 | 28633507 | |
| Pubmed | Congenital Hypothyroidism due to Oligogenic Mutations in Two Sudanese Families. | 1.68e-05 | 2 | 143 | 2 | 30375286 | |
| Pubmed | Cloning of two human thyroid cDNAs encoding new members of the NADPH oxidase family. | 1.68e-05 | 2 | 143 | 2 | 10806195 | |
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 11514595 | ||
| Pubmed | Roles of DUOX-mediated hydrogen peroxide in metabolism, host defense, and signaling. | 1.68e-05 | 2 | 143 | 2 | 24161126 | |
| Pubmed | Reactive oxygen species regulate the levels of dual oxidase (Duox1-2) in human neuroblastoma cells. | 1.68e-05 | 2 | 143 | 2 | 22523549 | |
| Pubmed | Expression of dual oxidases and secreted cytokines in chronic rhinosinusitis. | 1.68e-05 | 2 | 143 | 2 | 23281318 | |
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 31706280 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 11443211 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 10601291 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 15937072 | ||
| Pubmed | Dual oxidase-2 has an intrinsic Ca2+-dependent H2O2-generating activity. | 1.68e-05 | 2 | 143 | 2 | 15972824 | |
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 25586178 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 23362256 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 19144650 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 16111680 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 11762710 | ||
| Pubmed | Characterization of ThOX proteins as components of the thyroid H(2)O(2)-generating system. | 1.68e-05 | 2 | 143 | 2 | 11822874 | |
| Pubmed | Nox/Duox family of nicotinamide adenine dinucleotide (phosphate) oxidases. | 1.68e-05 | 2 | 143 | 2 | 11753072 | |
| Pubmed | Silencing of DUOX NADPH oxidases by promoter hypermethylation in lung cancer. | 1.68e-05 | 2 | 143 | 2 | 18281478 | |
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 15062544 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 9372911 | ||
| Pubmed | Regulated hydrogen peroxide production by Duox in human airway epithelial cells. | 1.68e-05 | 2 | 143 | 2 | 15677770 | |
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 18177232 | ||
| Pubmed | Genetic factors contributing to autism spectrum disorder in Williams-Beuren syndrome. | 1.68e-05 | 2 | 143 | 2 | 31413120 | |
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 29725036 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 24128054 | ||
| Pubmed | Dual oxidases represent novel hydrogen peroxide sources supporting mucosal surface host defense. | 1.68e-05 | 2 | 143 | 2 | 12824283 | |
| Pubmed | 2.40e-05 | 14 | 143 | 3 | 9373155 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | POLR2A GTF3C4 DDX5 MYOF TUBB4A DUOX1 FBP1 AP1G1 CTNNA1 ALDH1A1 STX16 DNM2 VAT1 | 3.09e-05 | 807 | 143 | 13 | 30575818 |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | VPS37C COL6A3 SEMA3C C11orf54 APOB MYOF TUBB4A SERPINB8 FBP1 HMCN1 ALDH1A1 CPNE4 GPRC5B DNM2 VAT1 | 3.71e-05 | 1070 | 143 | 15 | 23533145 |
| Pubmed | Genome duplications and other features in 12 Mb of DNA sequence from human chromosome 16p and 16q. | 4.04e-05 | 92 | 143 | 5 | 10493829 | |
| Pubmed | 4.29e-05 | 225 | 143 | 7 | 12168954 | ||
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | DARS2 CSDE1 MYOF RBM12 GIGYF2 CTNNA1 ATP5PD ADPGK TBCD DNM2 VAT1 | 4.53e-05 | 607 | 143 | 11 | 39147351 |
| Pubmed | 5.02e-05 | 3 | 143 | 2 | 27079415 | ||
| Pubmed | NADPH oxidase-dependent acid production in airway epithelial cells. | 5.02e-05 | 3 | 143 | 2 | 15210697 | |
| Pubmed | 5.02e-05 | 3 | 143 | 2 | 30885956 | ||
| Pubmed | 5.02e-05 | 3 | 143 | 2 | 24164541 | ||
| Pubmed | DUOX enzyme activity promotes AKT signalling in prostate cancer cells. | 5.02e-05 | 3 | 143 | 2 | 23225414 | |
| Pubmed | 5.02e-05 | 3 | 143 | 2 | 21915726 | ||
| Pubmed | 5.02e-05 | 3 | 143 | 2 | 32205481 | ||
| Pubmed | Complementary domains of retinoic acid production and degradation in the early chick embryo. | 5.02e-05 | 3 | 143 | 2 | 10588879 | |
| Pubmed | Association of duoxes with thyroid peroxidase and its regulation in thyrocytes. | 5.02e-05 | 3 | 143 | 2 | 19952225 | |
| Pubmed | LEMD3 POLR2A TFIP11 ERBIN GTF3C4 NOMO2 ZNF638 MIOS PEX5 SMG9 PCM1 VAT1 | 5.40e-05 | 733 | 143 | 12 | 34672954 | |
| Pubmed | Proximity labeling reveals dynamic changes in the SQSTM1 protein network. | 5.96e-05 | 322 | 143 | 8 | 39098523 | |
| Pubmed | 6.55e-05 | 421 | 143 | 9 | 36976175 | ||
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | ADGRG4 GTF3C4 DDX5 TUBB4A UBR5 ANAPC2 ANKIB1 PKP1 GIGYF2 PCM1 VAT1 | 7.16e-05 | 639 | 143 | 11 | 23443559 |
| Pubmed | PEX14 is required for microtubule-based peroxisome motility in human cells. | 7.39e-05 | 54 | 143 | 4 | 21525035 | |
| Pubmed | Leukodystrophy Overview – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY | 7.94e-05 | 55 | 143 | 4 | 24501781 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 9.16e-05 | 440 | 143 | 9 | 34244565 | |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | 9.43e-05 | 344 | 143 | 8 | 30333137 | |
| Pubmed | 1.00e-04 | 4 | 143 | 2 | 28292928 | ||
| Pubmed | Retinoic acid in the formation of the dorsoventral retina and its central projections. | 1.00e-04 | 4 | 143 | 2 | 10837133 | |
| Pubmed | 1.00e-04 | 4 | 143 | 2 | 23349811 | ||
| Pubmed | Nox4 and Duox1/2 Mediate Redox Activation of Mesenchymal Cell Migration by PDGF. | 1.00e-04 | 4 | 143 | 2 | 27110716 | |
| Pubmed | Synergism between p68 RNA helicase and the transcriptional coactivators CBP and p300. | 1.00e-04 | 4 | 143 | 2 | 12527917 | |
| Pubmed | 1.00e-04 | 4 | 143 | 2 | 26620705 | ||
| Pubmed | 1.00e-04 | 4 | 143 | 2 | 8912867 | ||
| Pubmed | Myoferlin regulates vascular endothelial growth factor receptor-2 stability and function. | 1.00e-04 | 4 | 143 | 2 | 17702744 | |
| Pubmed | The SAM domain of human TEL2 can abrogate transcriptional output from TEL1 (ETV-6) and ETS1/ETS2. | 1.00e-04 | 4 | 143 | 2 | 22615925 | |
| Pubmed | The type of DUOX-dependent ROS production is dictated by defined sequences in DUOXA. | 1.00e-04 | 4 | 143 | 2 | 22814254 | |
| Pubmed | Heterodimerization controls localization of Duox-DuoxA NADPH oxidases in airway cells. | 1.00e-04 | 4 | 143 | 2 | 19339556 | |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | RANBP10 HSP90B2P MAN2A2 LEMD3 ETV6 DARS2 NOMO1 RBM12 CSGALNACT2 MRPL14 AP1G1 NOMO2 PKP1 GFPT2 DNAH6 ADPGK NOMO3 | 1.02e-04 | 1451 | 143 | 17 | 30550785 |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | SH3BP2 POLR2A RIOK3 ERBIN DDX5 CSDE1 MLXIPL TUBB4A AP1G1 UBR5 PEX5 GIGYF2 TRAK2 RAPGEF2 | 1.02e-04 | 1038 | 143 | 14 | 26673895 |
| Pubmed | 1.13e-04 | 23 | 143 | 3 | 15766748 | ||
| Pubmed | Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer. | 1.17e-04 | 264 | 143 | 7 | 32814769 | |
| Pubmed | Control of a neuronal morphology program by an RNA-binding zinc finger protein, Unkempt. | 1.37e-04 | 271 | 143 | 7 | 25737280 | |
| Pubmed | 1.44e-04 | 64 | 143 | 4 | 22261194 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | ERCC6 POLR2A RIOK3 TFIP11 RRM2 ERBIN GTF3C4 DDX5 CSDE1 METTL13 MRPL14 AP1G1 UBR5 ANKIB1 ZNF638 PKP1 | 1.49e-04 | 1353 | 143 | 16 | 29467282 |
| Pubmed | 1.67e-04 | 5 | 143 | 2 | 16246722 | ||
| Pubmed | 1.67e-04 | 5 | 143 | 2 | 22869719 | ||
| Pubmed | GYF domain proteomics reveals interaction sites in known and novel target proteins. | 1.67e-04 | 5 | 143 | 2 | 16120600 | |
| Pubmed | Identification of a novel partner of duox: EFP1, a thioredoxin-related protein. | 1.67e-04 | 5 | 143 | 2 | 15561711 | |
| Pubmed | 1.67e-04 | 5 | 143 | 2 | 17696464 | ||
| Pubmed | 1.67e-04 | 5 | 143 | 2 | 16478776 | ||
| Pubmed | 1.67e-04 | 5 | 143 | 2 | 34784249 | ||
| Pubmed | 1.67e-04 | 5 | 143 | 2 | 12435728 | ||
| Pubmed | Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. | 1.79e-04 | 283 | 143 | 7 | 18854154 | |
| Pubmed | 2.14e-04 | 493 | 143 | 9 | 15368895 | ||
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | POLR2A RRM2 GTF3C4 DDX5 NOMO1 CSDE1 TUBB4A METTL13 UBR5 NOMO2 DHFR NOMO3 TBCD DNM2 VAT1 | 2.19e-04 | 1257 | 143 | 15 | 37317656 |
| Pubmed | 2.27e-04 | 497 | 143 | 9 | 23414517 | ||
| Pubmed | 2.30e-04 | 29 | 143 | 3 | 20167577 | ||
| Pubmed | 2.36e-04 | 209 | 143 | 6 | 36779422 | ||
| GeneFamily | Dyneins, axonemal | 1.02e-04 | 17 | 99 | 3 | 536 | |
| Coexpression | GSE27786_NKTCELL_VS_ERYTHROBLAST_DN | 1.40e-05 | 200 | 142 | 8 | M4867 | |
| Coexpression | GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_TREATED_DC_DN | 1.40e-05 | 200 | 142 | 8 | M6554 | |
| Coexpression | GSE3982_NEUTROPHIL_VS_BASOPHIL_DN | 1.40e-05 | 200 | 142 | 8 | M5525 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.28e-08 | 173 | 143 | 8 | e1378201b15ffb98e196ac39fe3ee4b4078953bd | |
| ToppCell | facs-Large_Intestine-Proximal-3m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.28e-08 | 173 | 143 | 8 | 99532bb768ee35fed939a377acb5215d3f8904bd | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.07e-07 | 192 | 143 | 8 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-07 | 194 | 143 | 8 | 4d7fc4d0a55abb3b645116d13a983bbedc55f70c | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.24e-07 | 194 | 143 | 8 | 5f5f0cdeacd5e1b28717d78dabdb9eb95f661e36 | |
| ToppCell | facs-Skin-Telogen-3m|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-07 | 194 | 143 | 8 | ba10fc5929649bb994c3f1d2ce6ca3167fa9b11b | |
| ToppCell | facs-Skin-Telogen|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-07 | 194 | 143 | 8 | bafecab8d48fc94ffd93f0d054b5f32c04b6b3f6 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.51e-07 | 197 | 143 | 8 | 5c4cee914baf7cb43e9cb99cc9e3ae823856dc15 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-Hepatocyte_(Pericentral_and_Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-06 | 165 | 143 | 7 | d449a568664a81d9b5538e8f409301448a32ac37 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-06 | 176 | 143 | 7 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 2.00e-06 | 181 | 143 | 7 | c80ffa2ded5975a88e9a1a7d333196f95237bf0a | |
| ToppCell | droplet-Kidney-nan-18m|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-06 | 184 | 143 | 7 | e02859bbac36dbbd55d7ae8cb5e46b764d7c6381 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.67e-06 | 189 | 143 | 7 | e9d5e858e320c6e9913c1ea6a54967d21eda605f | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.67e-06 | 189 | 143 | 7 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.76e-06 | 190 | 143 | 7 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.96e-06 | 192 | 143 | 7 | df1545670370fb1010c567cd059c2783eab315f7 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.96e-06 | 192 | 143 | 7 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.96e-06 | 192 | 143 | 7 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.96e-06 | 192 | 143 | 7 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | facs-Thymus-nan-3m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.17e-06 | 194 | 143 | 7 | f1661f9f2439fca5c1012c693b0744c4e3b90a9b | |
| ToppCell | facs-Thymus-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.17e-06 | 194 | 143 | 7 | cda1b197efb199330ea7ab25a7cee22cae22589d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.17e-06 | 194 | 143 | 7 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.17e-06 | 194 | 143 | 7 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | P15-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.17e-06 | 194 | 143 | 7 | 5f04d21c4e2d36e74b6c5889aa97fd98f75a0973 | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-06 | 195 | 143 | 7 | 79a6e8e6de040ff07539e8901fc407363a50e355 | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.39e-06 | 196 | 143 | 7 | ad1838dabd043cb140260843e3527d8c7d58850e | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.39e-06 | 196 | 143 | 7 | cbc15c0769016fe9972445169029bd8d14a7e6ef | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.51e-06 | 197 | 143 | 7 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Suprabasal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.63e-06 | 198 | 143 | 7 | 19d8ff3a4f911b13ecc34844202925475ad4d2ab | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.63e-06 | 198 | 143 | 7 | 5374b0e98d669f36a0571d3c006c7bd5e3c8e87f | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-06 | 199 | 143 | 7 | 8d50e1ee58710d896c0204937331d9f4dcd38de0 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.75e-06 | 199 | 143 | 7 | 94a7867e800df352731796de8c24cba133c29622 | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.87e-06 | 200 | 143 | 7 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.87e-06 | 200 | 143 | 7 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-1|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.41e-05 | 162 | 143 | 6 | 56f1789e69a6cb29956e46aba92b290847327c1f | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-05 | 168 | 143 | 6 | b98af4043dfa5dfa4413e482879fad88de484675 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-05 | 168 | 143 | 6 | 073b53d4cee6bc8c5c6fce51cf6cd9c316478f69 | |
| ToppCell | droplet-Liver-HEPATOCYTES|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-05 | 169 | 143 | 6 | f195467438c589f87224bde7da720dea072d110c | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-05 | 169 | 143 | 6 | 7785cab967a33560830c394c918d6ce625103858 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Enterocyte|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-05 | 174 | 143 | 6 | 2fbdb62e269acf4447b171700a615e878dde7f9f | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-enterocyte_of_epithelium_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-05 | 174 | 143 | 6 | 7c52b5d8f1e65e5208c952be341fa155ed0e6e76 | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_DCN|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.26e-05 | 176 | 143 | 6 | 08f94b78b27feeb113dbfadbfa7fe34d08b2809b | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-enterocyte_of_epithelium_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-05 | 176 | 143 | 6 | 7622f5a8e7320cc7b593141854107ecaf4adff7f | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-nan|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-05 | 176 | 143 | 6 | 1dd54bfaa58541de51e5a8328651d390833bd480 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.72e-05 | 182 | 143 | 6 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.98e-05 | 185 | 143 | 6 | 739260f8abebaf10a5cc49d91726278579e26170 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.98e-05 | 185 | 143 | 6 | d5f5866924648a3c14e2596218fd548a31777aa3 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-25|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.17e-05 | 187 | 143 | 6 | 0d4b7da81036c2aa678654b9fe49c939d08fcd9b | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.27e-05 | 188 | 143 | 6 | c32d023a69b6da79687ff8fa7485e7499db57046 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.27e-05 | 188 | 143 | 6 | 3177b2c1723268d330d3e9f24f9e24492ace6286 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.27e-05 | 188 | 143 | 6 | aa516273cdde53c8c0295f06830972388f890c97 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.27e-05 | 188 | 143 | 6 | 1cd5a4d744bd3777246958ea5eb94388a5cbad81 | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 3.36e-05 | 189 | 143 | 6 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.46e-05 | 190 | 143 | 6 | d60395739458d7f47a3350ade751fe3819500320 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-05 | 191 | 143 | 6 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.57e-05 | 191 | 143 | 6 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | ASK440-Mesenchymal|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.57e-05 | 191 | 143 | 6 | f12959eebb4167e1aa03de05d7711a702c58b3c9 | |
| ToppCell | (2)_Fibroblasts-(21)_Fibro-2|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 3.57e-05 | 191 | 143 | 6 | 5ee353c79055c08e8a3e2b43a0345bceb09f3890 | |
| ToppCell | ASK440-Mesenchymal-Fibroblast|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.57e-05 | 191 | 143 | 6 | 387296b5377ef6839f0812e5b3529a10b5f7d530 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.57e-05 | 191 | 143 | 6 | b55500eb416f4f339031acad16b2737e5b891d8e | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.57e-05 | 191 | 143 | 6 | b133ee1c0e58d00ddd2e4e05b01fd04947524c18 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-05 | 191 | 143 | 6 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-05 | 191 | 143 | 6 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-25|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.67e-05 | 192 | 143 | 6 | 30cefa0990ba1f379f350bfbf994a78db145075e | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.67e-05 | 192 | 143 | 6 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.67e-05 | 192 | 143 | 6 | 1b6cac8156e608061e1405e36e18d185b6fa8f6f | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.67e-05 | 192 | 143 | 6 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.78e-05 | 193 | 143 | 6 | 9f69edc97b868d23998abc98928a2e89a885ef8a | |
| ToppCell | facs-Heart-RV-18m-Myeloid-macrophage|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-05 | 193 | 143 | 6 | 77bc4353a1e9eae32bc6beb333577ba0294a10fc | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.78e-05 | 193 | 143 | 6 | cf2461af78f65616ce40d552ee9452295e3895ed | |
| ToppCell | facs-Heart-RV-18m-Myeloid-macrophage|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-05 | 193 | 143 | 6 | b9b431c18c81c616069a546cded4753563a1e701 | |
| ToppCell | facs-MAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-05 | 193 | 143 | 6 | f95b95c58a6edb8a03dd15ae166f47f9f33d8bd6 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.78e-05 | 193 | 143 | 6 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.78e-05 | 193 | 143 | 6 | 6ef9007c9d18fb775d08fb20cdf954a28d54d7eb | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 3.78e-05 | 193 | 143 | 6 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | facs-MAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-05 | 193 | 143 | 6 | 85faf6c5ce4769615a4eca036e2ba307e176bb52 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 3.78e-05 | 193 | 143 | 6 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.78e-05 | 193 | 143 | 6 | e4ea7ce011a80b81b841c907719aa532bed39d2e | |
| ToppCell | facs-MAT-Fat-3m-Mesenchymal|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-05 | 193 | 143 | 6 | 110a7d2ba7d066c2be38be98b643b76c520dd980 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.89e-05 | 194 | 143 | 6 | 756082a0f5953b52229bb60d40b84701cb6cb23d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.89e-05 | 194 | 143 | 6 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.89e-05 | 194 | 143 | 6 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.89e-05 | 194 | 143 | 6 | 66c056232ac216780acf4cc8ea325bd8ed1909c9 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.01e-05 | 195 | 143 | 6 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | NS-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.01e-05 | 195 | 143 | 6 | 34e37cff4849696ca4ba5dd8fd2cf98fed8bc912 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.12e-05 | 196 | 143 | 6 | b07db4a53ab9be9aad6fae5e45f9547db829d096 | |
| ToppCell | IPF-Stromal-Myofibroblast|IPF / Disease state, Lineage and Cell class | 4.12e-05 | 196 | 143 | 6 | 2d0a48e49b3b37bb66e33e74c52915911e1f8a74 | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.12e-05 | 196 | 143 | 6 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.12e-05 | 196 | 143 | 6 | 2029f58ce6a7b8c35d3a7496c3341391990909ce | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 4.12e-05 | 196 | 143 | 6 | 275e153347caf94edc0c50021bbab49c8696fecb | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.24e-05 | 197 | 143 | 6 | 0dd71e399f253787fa546a7e90c5373180b89ffd | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 4.24e-05 | 197 | 143 | 6 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.24e-05 | 197 | 143 | 6 | 9d7a1c7dc70ba5e35645f19f9e056e4fa2494aa0 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.24e-05 | 197 | 143 | 6 | c747c496ac090309b7f8a3e9d840928f12c83f2f | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 4.24e-05 | 197 | 143 | 6 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | facs-Tongue-nan-3m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.36e-05 | 198 | 143 | 6 | 2f03f8897dd7cce6d8296638e14e11ec16bcf624 | |
| ToppCell | Control_saline-Epithelial_airway|Control_saline / Treatment groups by lineage, cell group, cell type | 4.36e-05 | 198 | 143 | 6 | e6863238e022ecfb6a8e3f4b7661b376e92c5d8f | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-basal_cell_of_epidermis|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.36e-05 | 198 | 143 | 6 | 22559b161e67b49fe8028bfaf861e069063599f5 | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial|Control_saline / Treatment groups by lineage, cell group, cell type | 4.36e-05 | 198 | 143 | 6 | e7aa42e5fbd42c68f50cda4a8f3aa464c862c007 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 4.36e-05 | 198 | 143 | 6 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| Disease | phenylketonuria (implicated_via_orthology) | 1.22e-04 | 4 | 134 | 2 | DOID:9281 (implicated_via_orthology) | |
| Disease | triglyceride measurement, intermediate density lipoprotein measurement | 1.56e-04 | 111 | 134 | 5 | EFO_0004530, EFO_0008595 | |
| Disease | C-reactive protein measurement | DOCK3 CYP26A1 ETV6 APOB OR8J1 AGBL5 BCDIN3D MICU1 MLXIPL FBP1 HACL1 CTNNA1 CPNE4 CDH4 AFF4 | 3.94e-04 | 1206 | 134 | 15 | EFO_0004458 |
| Disease | Hodgkins lymphoma | 5.41e-04 | 82 | 134 | 4 | EFO_0000183 | |
| Disease | body shape measurement | 5.63e-04 | 8 | 134 | 2 | EFO_0801227 | |
| Disease | primary ovarian insufficiency (is_implicated_in) | 5.63e-04 | 8 | 134 | 2 | DOID:5426 (is_implicated_in) | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipid measurement | 6.43e-04 | 229 | 134 | 6 | EFO_0004639, EFO_0008317 | |
| Disease | primary bacterial infectious disease (implicated_via_orthology) | 7.22e-04 | 9 | 134 | 2 | DOID:0050338 (implicated_via_orthology) | |
| Disease | reaction time measurement | DNAH10 MLXIPL LIMK2 SERPINB8 PTPRO DHFR CCDC3 ZNF638 GIGYF2 DNM2 | 8.71e-04 | 658 | 134 | 10 | EFO_0008393 |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 8.75e-04 | 243 | 134 | 6 | EFO_0004612, EFO_0020944 | |
| Disease | level of Triacylglycerol (51:3) in blood serum | 8.99e-04 | 10 | 134 | 2 | OBA_2045163 | |
| Disease | PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER) | 1.10e-03 | 11 | 134 | 2 | C4721541 | |
| Disease | level of Diacylglycerol (18:1_18:1) in blood serum | 1.10e-03 | 11 | 134 | 2 | OBA_2045170 | |
| Disease | Infantile Refsum Disease (disorder) | 1.55e-03 | 13 | 134 | 2 | C0282527 | |
| Disease | hypothyroidism (implicated_via_orthology) | 1.55e-03 | 13 | 134 | 2 | DOID:1459 (implicated_via_orthology) | |
| Disease | serum albumin measurement | 1.57e-03 | 592 | 134 | 9 | EFO_0004535 | |
| Disease | congenital hypothyroidism (implicated_via_orthology) | 1.80e-03 | 14 | 134 | 2 | DOID:0050328 (implicated_via_orthology) | |
| Disease | triglycerides in medium VLDL measurement | 2.02e-03 | 55 | 134 | 3 | EFO_0022155 | |
| Disease | triacylglycerol 52:3 measurement | 2.07e-03 | 15 | 134 | 2 | EFO_0010415 | |
| Disease | Peroxisome biogenesis disorders | 2.07e-03 | 15 | 134 | 2 | C1832200 | |
| Disease | Adrenoleukodystrophy, Neonatal | 2.07e-03 | 15 | 134 | 2 | C0282525 | |
| Disease | triglycerides in large VLDL measurement | 2.13e-03 | 56 | 134 | 3 | EFO_0022178 | |
| Disease | triglycerides to total lipids in medium HDL percentage | 2.13e-03 | 56 | 134 | 3 | EFO_0022333 | |
| Disease | cholesteryl esters to total lipids in medium HDL percentage | 2.13e-03 | 56 | 134 | 3 | EFO_0022251 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 2.19e-03 | 291 | 134 | 6 | EFO_0008317, EFO_0020946 | |
| Disease | hematocrit | ASNSD1 CACNA1C RANBP10 ETV6 APOB DARS2 PRR12 KCNA4 A4GALT SMG9 CPNE4 STX16 | 2.25e-03 | 1011 | 134 | 12 | EFO_0004348 |
| Disease | Zellweger Syndrome | 2.36e-03 | 16 | 134 | 2 | C0043459 | |
| Disease | diffuse plaque measurement | 2.47e-03 | 758 | 134 | 10 | EFO_0010699 | |
| Disease | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | 2.55e-03 | 206 | 134 | 5 | EFO_0004612, EFO_0020947 | |
| Disease | cholesterol to total lipids in medium HDL percentage | 2.59e-03 | 60 | 134 | 3 | EFO_0022237 | |
| Disease | response to radiation, Urinary retention | 2.66e-03 | 17 | 134 | 2 | GO_0009314, HP_0000016 | |
| Disease | triglycerides in small VLDL measurement | 2.72e-03 | 61 | 134 | 3 | EFO_0022145 | |
| Disease | free cholesterol in very large VLDL measurement | 2.72e-03 | 61 | 134 | 3 | EFO_0022274 | |
| Disease | phospholipids in large VLDL measurement | 2.85e-03 | 62 | 134 | 3 | EFO_0022169 | |
| Disease | triglycerides to total lipids in very large HDL percentage | 2.85e-03 | 62 | 134 | 3 | EFO_0022339 | |
| Disease | total lipids in very large VLDL measurement | 2.85e-03 | 62 | 134 | 3 | EFO_0022313 | |
| Disease | phospholipids in very large VLDL measurement | 2.85e-03 | 62 | 134 | 3 | EFO_0022299 | |
| Disease | central corneal thickness | 2.94e-03 | 309 | 134 | 6 | EFO_0005213 | |
| Disease | Age-related macular degeneration | 2.99e-03 | 18 | 134 | 2 | cv:C0242383 | |
| Disease | susceptibility to hepatitis B infection measurement | 3.12e-03 | 64 | 134 | 3 | EFO_0008405 | |
| Disease | total cholesterol measurement, high density lipoprotein cholesterol measurement | 3.24e-03 | 315 | 134 | 6 | EFO_0004574, EFO_0004612 | |
| Disease | cholesterol in large VLDL measurement | 3.26e-03 | 65 | 134 | 3 | EFO_0021902 | |
| Disease | cholesterol in very large VLDL measurement | 3.26e-03 | 65 | 134 | 3 | EFO_0022230 | |
| Disease | apolipoprotein B measurement | 3.36e-03 | 663 | 134 | 9 | EFO_0004615 | |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 3.38e-03 | 220 | 134 | 5 | EFO_0004529, EFO_0008317 | |
| Disease | phospholipid measurement, high density lipoprotein cholesterol measurement | 3.55e-03 | 321 | 134 | 6 | EFO_0004612, EFO_0004639 | |
| Disease | total lipids in small VLDL | 3.55e-03 | 67 | 134 | 3 | EFO_0022148 | |
| Disease | total lipids in large VLDL | 3.55e-03 | 67 | 134 | 3 | EFO_0022175 | |
| Disease | attention deficit hyperactivity disorder (is_implicated_in) | 3.69e-03 | 20 | 134 | 2 | DOID:1094 (is_implicated_in) | |
| Disease | triglycerides to phosphoglycerides ratio | 3.70e-03 | 68 | 134 | 3 | EFO_0022327 | |
| Disease | free cholesterol in large VLDL measurement | 3.70e-03 | 68 | 134 | 3 | EFO_0022265 | |
| Disease | cholesterol in very large HDL measurement | 3.86e-03 | 69 | 134 | 3 | EFO_0022229 | |
| Disease | lipid measurement, high density lipoprotein cholesterol measurement | 4.06e-03 | 330 | 134 | 6 | EFO_0004529, EFO_0004612 | |
| Disease | triglycerides to total lipids in small HDL percentage | 4.35e-03 | 72 | 134 | 3 | EFO_0022336 | |
| Disease | depressive disorder (implicated_via_orthology) | 4.46e-03 | 22 | 134 | 2 | DOID:1596 (implicated_via_orthology) | |
| Disease | CCL24 measurement | 4.46e-03 | 22 | 134 | 2 | EFO_0009418 | |
| Disease | triglyceride measurement, phospholipid measurement | 4.49e-03 | 146 | 134 | 4 | EFO_0004530, EFO_0004639 | |
| Disease | total blood protein measurement | 4.53e-03 | 449 | 134 | 7 | EFO_0004536 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LPRMFAVQQAADFES | 96 | A8MZ25 | |
| PTFEMTETQFVLSFV | 126 | Q8NDL9 | |
| PRTEDVMFISDNESF | 431 | Q96RT1 | |
| NMLEVFVSSLEEFQP | 241 | Q9BRR6 | |
| TTMAIPLTFDFQLEF | 36 | Q5JVX7 | |
| LFFSTPRTFQEMIQR | 161 | Q9UJX6 | |
| SVQNSPDDLERFVMV | 551 | Q9NQ75 | |
| QTLMFSATFPEEIQR | 476 | Q9NQI0 | |
| FLETSDRTNPNFLFM | 81 | Q9NPC4 | |
| NFQDVSLPRVEDAMS | 531 | Q8IZF6 | |
| VFPMTSIEQVLNDFS | 266 | Q9UKJ8 | |
| PDALTFITLDFMNQR | 126 | Q7Z5W3 | |
| IPFDQMTIEDLNEAF | 126 | O75947 | |
| VMRAAEETTSNNVFP | 81 | P78314 | |
| FTAMVSTPENRQTFI | 106 | Q9BZP6 | |
| NLESQMVFSRDPEAE | 196 | Q9P2G1 | |
| FVQPTVFSNVTDEMR | 381 | P00352 | |
| VEFTVVPDMLSAQRN | 391 | O75534 | |
| PDFLGTRQEFSNMFE | 511 | Q9Y4B4 | |
| AMFPNRRIVTTVFND | 1096 | Q6DHV5 | |
| VEEEDSFFRQRMFSP | 681 | Q9UHB7 | |
| QNMPFTVSIDEILDF | 861 | Q9NTZ6 | |
| AFARMTETPIQEEQA | 276 | Q6VN20 | |
| KEFRFEPSSQMIEVQ | 931 | P69849 | |
| MESPNRTTIQEFIFS | 1 | Q8NGY2 | |
| MPDSNFAERSEEQVS | 1 | Q9UJ83 | |
| TDVQFLQSTRPLMSF | 606 | Q9Y2U8 | |
| TELDMTDFVFQAAVP | 741 | O43747 | |
| EFVAASEQFLSTMVP | 321 | Q9NRD9 | |
| NDFFTVMRTPTEILE | 601 | P0DP91 | |
| EFSLRPIDSNTFEMN | 76 | P41212 | |
| TDDFRDTMPKNLNFV | 76 | Q58FF3 | |
| KEFRFEPSSQMIEVQ | 931 | Q5JPE7 | |
| FRSFMPEDGQVNISI | 696 | Q8N653 | |
| RMFPDLESEFQAAIS | 96 | P43356 | |
| APMFERLSTESVQEQ | 131 | P53671 | |
| QMEDVTSTFIAPRNE | 786 | Q8IYD8 | |
| MDVIARQNFTEPTAI | 106 | P17844 | |
| PEFVVASEQFFSTMV | 326 | Q9NRD8 | |
| SPEEFTEIMNQREQF | 456 | P54868 | |
| FMTPEDFVRSITPNE | 146 | Q9BPX6 | |
| RQFDEESLESFSSMP | 1251 | Q15154 | |
| PEVTFMSFSNQIPED | 341 | Q9Y5G3 | |
| LLDNMAEFFRPTEQD | 291 | P56589 | |
| FTRPVNTSALDMEFE | 261 | P50542 | |
| SSEQEFQMFPKSRLS | 231 | P15036 | |
| LFVDPARDNFRTMTS | 136 | Q5QP82 | |
| FRPMEVQLTDFENSA | 426 | P48506 | |
| KEFRFEPSSQMIEVQ | 931 | Q15155 | |
| RALEPSAVQEEFMTS | 1081 | P54098 | |
| MPFQDGQEFELSISV | 81 | Q05315 | |
| MAPENFTRVTEFILT | 1 | Q8NGG0 | |
| NTFSMDPQLERQVET | 641 | P50570 | |
| QVMPSDSFFFSIVRD | 146 | Q96RP7 | |
| ETPNARAVIMFANED | 271 | O00222 | |
| QFTFEFMTPDLTRTV | 471 | Q3SYG4 | |
| RTTFLMVDEEQTVPF | 5566 | Q96RW7 | |
| EEQSGNFPEESFMRS | 241 | Q16827 | |
| NFPEESFMRSQDTIG | 246 | Q16827 | |
| SQPRMRETAFEEDVQ | 311 | Q9NZH0 | |
| PFDTDVNTLTRFVME | 6 | P09467 | |
| MAPENFTRVTEFILT | 1 | Q8NGP2 | |
| VNVEVSPFTIEMSAF | 3256 | P04114 | |
| VPLAERTEAFVQFMQ | 276 | Q8N6G5 | |
| RAFTEMTPSFFEENI | 3666 | Q9C0G6 | |
| EREVQIVSTMDSSFP | 66 | O75054 | |
| EMQTRRSTFDNFPQS | 681 | Q13936 | |
| SFPTIFDELLQMFTV | 791 | Q8IZD9 | |
| NTVMPRFTEQVEAAV | 581 | P35221 | |
| LVPFTEEEQRNFSMS | 81 | Q6Y7W6 | |
| FEQPESVFNTMRGRV | 331 | O94808 | |
| FEFEVTPQETVMENN | 3996 | Q8TD57 | |
| DAIFPDTQENRRMFS | 141 | Q9BQI4 | |
| QVAMVQFTDDPRTEF | 1071 | Q05707 | |
| ISDPSFSMVTVQRED | 66 | Q8N3K9 | |
| DPFLEIFRMNDDATQ | 176 | Q96A23 | |
| VTRIMQDFESDTFFP | 136 | P00374 | |
| DITEMQTISFIPDFA | 1171 | P12111 | |
| DSFQPMDDSLIAFRT | 481 | Q3T8J9 | |
| NMFTPFFSAQDVLEE | 11 | A6NGH7 | |
| LTTFSAVDPDRFMQQ | 526 | P55283 | |
| SAVTMERFEPQINAE | 486 | P32189 | |
| SFPEAEDSLLQQMFI | 481 | Q8NEU8 | |
| VLFNPLEQERFSMVS | 651 | P49641 | |
| FIAEEKTMPTTFNRE | 356 | Q9NWL6 | |
| VEAFEEMTRNLFSLP | 211 | O43174 | |
| TQMEFPDASFQVVLD | 106 | Q8N6R0 | |
| PNFLRSLMEIDFDSI | 3191 | Q8IVF4 | |
| AMDSFLRSLQPEVND | 311 | O00237 | |
| QEEEVTMVTARPNFQ | 836 | Q58EX2 | |
| VSEFRFIPNQTEAME | 226 | Q9H329 | |
| ERTDQPFQTELNTSM | 181 | Q659C4 | |
| PVFFINTEKFQTMES | 276 | Q99487 | |
| FFEMLPSSEFQISVV | 61 | Q9UKK6 | |
| SNMSREVVDPEVFFN | 391 | Q13835 | |
| TTTALEMPDRENTFV | 331 | Q9NRF2 | |
| PEFTQIDIEMSFVDQ | 276 | Q6PI48 | |
| NMRTTKEFPDDVVTF | 386 | Q99985 | |
| MTPRFDSNNVVLIED | 96 | Q6P1L8 | |
| IQLSTDKFFRMEPSE | 481 | Q8NE18 | |
| FSVDSFQIVLDPMLD | 171 | Q8NEK8 | |
| VNLFLVPFMDSEAES | 426 | Q9H0W8 | |
| TEPFEENSFLEQFMI | 181 | Q9H9Q4 | |
| TLMRPDFENREFLST | 1416 | Q13017 | |
| MEITIRNDTFSDSPV | 831 | Q8IX21 | |
| DSLLQDEERSFFPTM | 936 | Q9ULL5 | |
| PGELMEFFDEQVRSN | 311 | Q7Z745 | |
| FMDISDFFTNSRLPQ | 296 | Q9NP71 | |
| EEDNSRNVFFSPMSI | 21 | P50452 | |
| KTQRDFMLSFSTDPQ | 451 | Q92925 | |
| FMLSFSTDPQDFIQE | 456 | Q92925 | |
| FSSLFSEERMDVQPF | 1186 | O94911 | |
| FFLTPRMESSSLENV | 326 | Q76KP1 | |
| NFPEAFSTEVSKMRE | 111 | Q8IYE0 | |
| GFNSEFMPVIQTESE | 106 | Q9H0W9 | |
| TARMENFAPEFQVGD | 176 | O14730 | |
| SMRNFELFRNIEPTE | 726 | Q9Y4G8 | |
| MTVQLVSNFSRDAEP | 511 | Q8N1K5 | |
| NFLASRPAETFLQEM | 801 | O60296 | |
| MDPVAFEDVAVNFTQ | 21 | Q9H0M5 | |
| PVSERMNALFVQFAE | 31 | Q8NCS4 | |
| SFSDMSIFDLPQQIR | 156 | Q9UK11 | |
| VTPNRTMSDFTVFER | 341 | Q9NXC5 | |
| FRVENPFDFMENISL | 341 | P31350 | |
| REEFPDRIMNTFSVV | 156 | P04350 | |
| EERSQHFFDTSVPLM | 191 | O14662 | |
| ANMTFAEIVTPFNID | 386 | P24928 | |
| QNVVDSFFPRSMTRF | 186 | Q9NSY2 | |
| EFDKNDRLSSVTMPN | 1946 | Q6N022 | |
| KTMRFTFNERSNPDD | 276 | Q9Y2I9 | |
| VSQTFMLDRVFNPEG | 141 | Q9UKN8 | |
| RRAEMSQTNFTPDTL | 101 | Q8TCN5 | |
| SVQTFLIPEAMTFEE | 151 | Q99536 | |
| QSSKMTDLFIRFPEN | 206 | Q96MP5 | |
| PLQQRMSEEVSFQSE | 86 | Q5JVG2 | |
| ARPELLEVFSTEFQM | 806 | Q8N5H7 | |
| EFSATQVFPRLLSMT | 596 | Q9BTW9 | |
| EVEFPDQFFTVLTMD | 21 | Q6P280 | |
| EVPLETFLENFSSMR | 126 | A5D8V6 | |
| EEIPFEQSFSIGMSQ | 116 | Q68DY9 | |
| ERTTQSMQDFPVVDS | 196 | Q9UBB9 | |
| EDVFRQMDFPGESSN | 266 | Q14966 | |
| DVIMVFQFPSTEQRA | 116 | Q6ZMR5 | |
| QETFMLDEPLERTTN | 1686 | O95071 | |
| RFETQMKTLAQFPET | 186 | P22459 | |
| RAEDIPQMDDAFSQT | 366 | Q9NZM1 |